Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 23S ribosomal RNA (rRNA) peptidyl transferase center (PTC) is the catalytic core of the bacterial 50S ribosomal subunit, functioning as a ribozyme that facilitates peptide bond formation (Polacek & Mankin, 2005, Crit Rev Biochem Mol Biol). It plays a fundamental role in translation by orienting the 3' ends of A-site and P-site tRNAs to allow the nucleophilic attack of the aminoacyl-tRNA on the peptidyl-tRNA. Due to its vital role in bacterial growth and its structural divergence from eukaryotic cytoplasmic ribosomes, the PTC is a major target for diverse classes of antibiotics, including oxazolidinones, macrolides, and lincosamides (Wilson, 2014, Cold Spring Harb Perspect Med). These agents interfere with protein synthesis by either directly inhibiting the peptidyl transferase reaction or by sterically hindering the passage of the growing polypeptide chain through the exit tunnel. Clinical challenges associated with targeting the PTC include the emergence of resistance through rRNA methylation or mutations and potential off-target effects on human mitochondrial ribosomes (Vester & Douthwaite, 2001, Antimicrob Agents Chemother). Consequently, the PTC remains a focal point for the design of novel antimicrobial agents aimed at overcoming drug-resistant pathogens.
Inhibition of bacterial protein synthesis by binding to the 23S rRNA within the 50S ribosomal subunit, thereby blocking peptide bond formation or obstructing the nascent peptide exit tunnel (Wilson, 2014, Cold Spring Harb Perspect Med).
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 23S ribosomal RNA peptidyl transferase center (PTC) (PTC).